Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech for less than a buck. -- Ignore unavailable to you. Want to Upgrade?

To: RWReeves who wrote (219)	12/3/1999 1:33:00 PM
From: Mike McFarland	Respond to of 743

Regarding CNSI...my thought on that, the reason I'm holding that supersized position: Does it not seem odd that they would be spending all the effort for these rhGGF2 patents if they were not terribly optimistic for the growth factor? Also, Cambridge really seemed to cut away a lot of the things they had going, they gave up another growth factor and are really concentrated on just this one effort. They have some sort of an 'ion channel program', if anybody can value it would be useful. They also seem not to be interested in touting themselves, sneaking around down there on the OTCBB. I should think Bayer has made some offers, but a buyout takes away the greatest potential, so maybe this is going to be a long term investment. Rick is always looking for leverage, I think you have that in CNSI. I've no reason to expect it to run up right now however, an extra trading position was reasonable the day of that last PR, but it seems to have been ignored, so I'd be chasing genomics with cash instead-- but I wont give etrade the $20 to undo the idea. Now the first three symbols you mention... I just have investments there, should probably be trading the volatility in MAGN, but I've become all sentimental for the long term prospects for Squalamine. Yeah I'd sell a little on a Pex Pop, but for the most part I'm done trading those. I've said it before, and I know mostly I just repeat myself on these threads, but there is nothing wrong with making an investment and then just walking away from the quotes. long term holds now.

To: RWReeves who wrote (219)	12/3/1999 2:06:00 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 743

Thanks, Richard. Got an OTC price prediction, in any event? Know of other CDER stuff that has gone straight to OTC? What's your take on what is going on? The train of CFOs may have ended. Efficacy is roughly equivalent to topical aciclovir, nothing to write home about. Topical cidofovir looked sensational in immunosuppressed patients, but then sort of disappeared. Guess the toxicities discouraged the extension of studies to normals.